Stay updated on SB17 vs Stelara in Plaque Psoriasis Clinical Trial
Sign up to get notified when there's something new on the SB17 vs Stelara in Plaque Psoriasis Clinical Trial page.

Latest updates to the SB17 vs Stelara in Plaque Psoriasis Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedGlossary display was added and the page metadata now shows Last Update Submitted that Met QC Criteria and Revision: v3.4.0, while the older entries Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check22 days agoChange DetectedThe page shows a new revision: v3.3.4 replacing v3.3.3 (maintenance update). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedAdded Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page shows a revision update from v3.3.1 to v3.3.2. No changes to study details or core information are visible in the screenshot. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed; this is a minor metadata update that does not alter study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to SB17 vs Stelara in Plaque Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SB17 vs Stelara in Plaque Psoriasis Clinical Trial page.